Second Primary Cancer Risk of Radiation Therapy After Radical Prostatectomy for Prostate Cancer: An Analysis of SEER Data

Urology

Volumn 74, Issue 4, 2009, Pages 866-871

  Abdel Wahab, May ^a   Reis, Isildinha M ^a,b   Wu, Jiuhua ^a,c   Duncan, Robert ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c Biostatistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; COLON CANCER; ETHNICITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RACE; RECTUM CANCER; SECOND CANCER; SKIN CANCER;

AGED; COMBINED MODALITY THERAPY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM;

EID: 70349467859     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.02.085     Document Type: Article

References (23)

1. Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291 (2004) 1325-1332
2. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
3. Thompson I., Tangen C., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 296 (2006) 2329-2335
4. Alberts D. Second cancers are killing us!. Cancer Epidemiol Biomarkers Prev 15 (2006) 2019
5. Hall E.J., and Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
6. Amemiya K., Shibuya H., Yoshimura R., et al. The risk of radiation-induced cancer in patients with squamous cell carcinoma of the head and neck and its results of treatment. Br J Radiol 78 (2005) 1028-1033
7. Warren S., and Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 16 (1932) 1358-1414
8. Cahan W.G., Woodward H.Q., Higinbotham N.L., et al. Sarcoma arising in irradiated bone. Cancer 1 (1948) 3-29
9. Moon K., Stukenborg G., Keim J., et al. Cancer incidence after localized therapy for prostate cancer. Cancer 107 (2006) 991-998
10. Kendal W.S., Eapen L., Macrae R., et al. Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. Int J Radiat Oncol Biol Phys 65 (2006) 661-668
11. Chrouser K., Leibovich B., Bergstralh E., et al. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 174 (2005) 107-110
12. Pickles T., and Phillips N. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Radiother Oncol 65 (2002) 145-151
13. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2003). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission. http://www.seer.cancer.gov
14. Rothman K., and Greenland S. Modern Epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia 260-264
15. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1154
16. The R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Version 2.8.0 2008/10/20 ISBN: 3-9000-51-07-0. http://cran.r-project.org/doc/manuals/refman.pdf
17. Fine J.P., and Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999) 496-509
18. Pawlish K.S., Scottenfeld D., Severson R., et al. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study. Prostate 33 (1997) 75-86
19. Neugat A.I., Ahsan H., Robinson E., et al. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 79 (1997) 1600-1604
20. Liauw S.L., Sylvester J.E., Morris C.G., et al. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66 (2006) 669-673
21. Brenner D.J., Curtis R.E., Hall E.J., et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-406
22. Movsas B., Hanlon A.L., Pinover W., et al. Is there an increased risk of second primaries following prostate irradiation?. Int J Radiat Oncol Biol Phys 41 (1998) 251-255
23. Abdel-Wahab M., Reis I., and Hamilton K. Second primary cancer after radiation therapy for prostate cancer-a SEER analysis of brachytherapy versus external beam radiation. Int J Radiat Oncol Biol Phys 72 (2007) 58-68